Delivering drugs and therapies into cells at the nanoscale helps eliminate toxic effects that have stymied similar efforts.
By Addy Hatch, WSU Spokane
SPOKANE, Wash. – Marian Wilson, an assistant professor at the WSU College of Nursing, is joining a team of scientists who’ll lead a federally funded, $2.5 million study investigating whether an online pain management program can help patients with chronic pain reduce or eliminate the amount of prescription opioids they take.
PULLMAN, Wash. – Biochemist James A. Wells, a pioneering engineer of proteins, antibodies and small molecules that target cell sites to thwart disease and enhance drug therapies, will receive the Regents’ Distinguished Alumnus Award at 3:45 p.m. Wednesday, Jan. 25, in the CUB auditorium at Washington State University.
By Scott Weybright, College of Agricultural, Human & Natural Resource Sciences
PULLMAN, Wash. – Work on a new anti-inflammatory drug developed from the medicinal/spice plant turmeric recently received funding from a $225,000 grant from the National Institutes of Health National Center for Complementary and Integrative Health (NIH-NCCIH).
PULLMAN – WSU’s College of Veterinary Medicine is offering a financial incentive to pet owners whose dogs participate in a clinical trial regarding B cell lymphoma, a type of blood cell cancer.
Artemisinin is a drug derived from the plant Artemisia annua. It has been traditionally used by Chinese herbalists in the treatment of skin diseases and malaria. In addition to its well-known antimalarial properties, the drug has recently aroused interest as an anticancer drug.
In the laboratory, the drug causes cancer cell death and changes that could sensitize cancers making them more susceptible to common chemotherapy … » More …